CAN PRIOR INDIRECT TREATMENT COMPARISONS (ITCS) INFORM HEALTH TECHNOLOGY ASSESSMENT (HTA) STRATEGY: A CASE STUDY IN RELAPSED-REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR-DLBCL)-MedSci.cn

CAN PRIOR INDIRECT TREATMENT COMPARISONS (ITCS) INFORM HEALTH TECHNOLOGY ASSESSMENT (HTA) STRATEGY: A CASE STUDY IN RELAPSED-REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR-DLBCL)

Forsythe, A; Heeg, B; Tordoff-Gibson, C; Springford, A

VALUE IN HEALTH, 2023; 26 (12): S363

科室
- - 订阅+
  - 更多科室
工具
服务